Immune Response to a Delayed Second Dose of Oral Cholera Vaccine

Clinical trial NCT05453253 · UNKNOWN

Trial details

NCT number: NCT05453253
Sponsor: Epicentre
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Cholera Vibrio Cholerae Infection

Start date: 2022-07-20
Primary completion: 2024-02-01
Enrollment: 456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.